Notes to the Financial Statement

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 1-10
NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 11-20
NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS 21-30
NOTES TO THE PARENT COMPANY FINANCIAL STATEMENTS 31-44
Displaying Notes 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 out of total 44 notes

(Figures are in EUR thousands unless otherwise stated)	31 Jan 2007	31 Jan 2006
NOTES TO THE CONSOLIDATED INCOME STATEMENT
1. NET SALES BY MARKET AREA AND UNIT, EUR MILLION
By market area:
Sweden	1,740.0	1,590.5
Denmark	1,309.2	1,224.2
Finland	1,068.9	1,098.1
Norway	731.6	709.4
Poland	347.8	0.0
Baltic States	266.5	225.6
Others	0.5	9.0
	5,464.5	4,856.8
By unit:
Tamro Sweden	1,708.4	1,536.3
Tamro Denmark	1,334.8	1,230.9
Tamro Finland	1,040.6	1,039.1
Tamro Norway	723.2	699.5
Tamro Poland	347.9	0.0
Tamro Baltics	270.4	225.5
Tamro MedLab	61.2	132.5
Others	-22.0	-7.0
	5,464.5	4,856.8
2. OTHER INCOME
Gain on sale of fixed assets	6,302	7,576
3. RAW MATERIALS AND SERVICES
Raw materials and consumables
Purchases during the financial period	5,050,168	4,411,749
Inventories, incr. (-), decr. (+)	-52,588	1,983
External services	30,615	28,347
Raw materials and services total	5,028,195	4,442,079
4. PERSONNEL EXPENSES
Average personnel by unit:
Tamro Sweden	440	448
Tamro Denmark	634	614
Tamro Finland	335	332
Tamro Norway	1,803	1,650
Tamro Poland	321	-
Tamro Baltics	1,003	882
Tamro MedLab	133	274
Others	24	23
	4,693	4,223
Personnel expenses:
Wages and salaries during the financial year	160,696	153,664
Payroll related social costs
Pension costs	9,604	7,442
Other payroll related social costs	24,251	24,588
	194,551	185,694
Wages and salaries paid to:
Boards of Directors, CEO and Managing Directors	4,866	4,499
Pension commitments for Board Members, CEO and Managing Directors: The parent company has no pension liabilities for Board Members. The pensionable age of the CEO has been stipulated at 60 years.
Other pension commitments: The Group has no significant pension commitments for the management.
5. DEPRECIATION AND VALUE ADJUSTMENTS
Depreciation/amortisation according to plan
Intangible rights	912	906
Goodwill	11,661	10,334
Consolidated goodwill	1,045	1,699
Other capitalised expenditure	165	86
Buildings	7,396	7,439
Machinery and equipment	12,248	14,183
Other tangible assets	308	284
	33,735	34,931
6. FINANCIAL INCOME AND EXPENSES	31 Jan 2007	31 Jan 2006
Income from non-current financial assets
Dividend income	653	-30
Interest income	968	151
Other interest and financial income
Interest income	2,024	1,251
Other interest and financial expenses
Interest expenses	-6,707	-5,361
Other financial expenses	-2,965	-2,025
Exchange rate differences, net	-177	342
	-6,204	-5,672
7.EXTRAORDINARY INCOME AND EXPENSES
Gain on sale of MedLab business	48,496	-
8. INCOME TAXES
Income taxes on ordinary activities
Finnish Group companies	-3,658	-2,387
Foreign Group companies	-17,037	-13,752
	-20,695	-16,139
Income taxes from previous years	-73	73
Change in deferred tax liability specified in note 20	-12,480	-11,985
Income taxes total	-33,248	-28,051

NOTES TO THE CONSOLIDATED BALANCE SHEET
9. FIXED ASSETS
	Intangible assets					Tangible assets
	Intangible rights	Goodwill	Consoli- dated goodwill	Other capital- ised expen- diture	Advance pay- ments and cons- truction in progress	Land areas	Buildings	Machinery and equipment	Other tangible assets	Advance pay- ments and cons- truction in progress
Acquisition value 1 Feb 2006	15,821	201,262	71,726	6,952	1,174	9,566	153,849	141,697	2,359	6,672
Increase	1,231	16,102	-5,636	133	1,105	868	14,906	18,234	599	563
Decrease	-1,888	-2,400	-8,022	-698		-1,103	-9,651	-13,128	-454	-89
Other changes				-45			4,938	1,655	144	-6,691
Acquisition value 31 Jan 2007	15,164	214,964	58,068	6,342	2,279	9,331	164,042	148,458	2,648	455
Accumulated depr. 1 Feb 2006	-12,926	-33,887	-56,935	-6,138			-65,612	-112,364	-1,305	0
Increase	-912	-11,661	-1,045	-165			-7,396	-12,248	-308
Decrease	1,309	596	4,084	524			4,186	11,292	346
Other changes	-612	-79					-1,340	-2,426	-38
Accumulated depr. 31 Jan 2007	-13,141	-45,031	-53,896	-5,779	0	0	-70,162	-115,746	-1,305	0
Value adjustments 1 Feb 2006 & 31 Jan 2007						420	2,355
Translation difference	1	-974		2		72	342	161	0	8
Bookvalue 31 Jan 2007	2,024	168,959	4,172	565	2,279	9,823	96,577	32,873	1,343	463
Bookvalue 31 Jan 2006	2,895	167,375	14,791	814	1,174	9,986	90,592	29,333	1,054	6,672
Value adjustments relate to the parent company only (from 1988). Deferred tax liability (EUR 722,000) has not been accounted for. Value adjutments related to fixed assets are not considered as a normal accounting practice of the Group.

	31 Jan 2007	31 Jan 2006
Machinery and equipment in production use, book value	7	99
10. ASSOCIATED COMPANIES
Opening balance	4,151	7,315
New associated companies	14,814	0
Write-down of the shares	-243	0
Associated companies converted into subsidiaries	-1,907	-3,210
Share of net results	206	287
Translation differences	-8	176
Other differences	-17	-417
Closing balance	16,996	4,151
	Group sharere of holding %	Parent company share of holding %
OÜ Mai Apteek, Pärnu, Estonia	49.0	-
Svolvaer Apotek AS, Svolvaer, Norway	49.0	-
ZAO Rosta	42.5	42.5
Namsos Apotek AS, Namsos, Norway	34.0	-
OÜ Ravikeskuse, Viimsi, Estonia	33.0	-
Soft Design A/S, Copenhagen, Denmark	29.8	-
Websydian A/S, Copenhagen, Denmark	29.8	-
The associated companies have been consolidated using the equity method. Included in the associated companies is undepreciated goodwill amounting to EUR 1.144  thousand.
Other shares and participations
Golf shares	83
OMX Plc	27
Telephone company shares etc.	7
Real estate and other shares	180
	297

Displaying Notes 1, 2, 3, 4, 5, 6, 7, 8. 9, 10 out of total 44 notes